United States: Massachusetts

Firms: litigation

Firms: prosecution

Firms: transactions

Choate Hall & Stewart LLP

Choate’s patent practice has all the bases covered; the many PhDs on deck cultivate wide-ranging technical supremacy in a team that prosecutes, litigates and monetises IP rights with alacrity. On the counselling side, the group manifests a rare faculty for analysing incredibly dense patent landscapes and advising on where risk and opportunity lies, which adds tremendous value for life sciences clients. The master in this regard is IP co-chair Charles Lyon, an Oxford, Cambridge and Massachusetts Institute of Technology educated biophysical chemist and transactional ace. Strategic wisdom is also supplied in abundance by life sciences group co-chair Brenda Herschbach Jarrell; a biochemistry and molecular biology PhD, she loves digging into the science but overlays her knowledge of the tech with a rigorously business-minded approach. Choate is by no means lacking when it comes to contentious firepower – great leadership is supplied to the IP litigation group by co-leaders Michael Bunis and Eric Marandett, two high-tech and life sciences trial lawyers who garner excellent references. “Michael is a smart, tough litigator who understands the goals of his clients which he works diligently to achieve.” “Eric is one of the best in the business on case development and strategy. He is also brilliant at presenting in court, making sure juries of non-scientists understand the key issues in a case and are convinced by his arguments; a good negotiator, too, he understands when the correct time is to settle instead of continuing to fight a case. He also performs exceptionally well in large teams which he coordinates effectively thanks to excellent interpersonal skills and emotional intelligence.” The uptick in trade secret litigation in the market has placed a premium on the expertise offered by Paul Popeo, who is an authority in the area. Bringing his A-game to software, computer, networking and telecoms matters, Carlos Perez-Albuerne demonstrates versatility as an IP litigator battling patent, trade secret and copyright cases across the land. Finally, former managing partner and chair Robert Frank brings decades of frontline litigation experience to the group.

Clark+Elbing LLP 

Life sciences and IP boutique Clark+Elbing is admired for its exceptional academic credentials and the scientific passion it demonstrates through its work. It offers a wide spectrum of prosecution, counselling, opinion, licensing and due diligence services, making it an effective one-stop shop for chemical, pharmaceutical and biotechnology companies as they protect and commercialise their intellectual property. Co-founding partner and Harvard genetics PhD Karen L Elbing is the person to call if you want to stake out a strong position in a highly competitive market.

Cooley LLP

Cooley is a “national leader in the transactional space” and a “top firm for life sciences”. Anchoring the practice in Boston is organic chemistry PhD Dean Farmer; he manages the portfolios of well-established pharmaceutical and biotechnology companies with a deft touch and is also a pathfinder for start-ups. Commentators acknowledge the firm’s strong local push and highlight the work of Scott Weston, who makes his debut in the IAM Patent 1000 for 2019. “Scott is a fantastic choice for emerging companies and is someone you can trust for no-nonsense, practical advice.” His skill set is broad and encompasses prosecution, portfolio development, litigation, due diligence and more; medical technology and energy are his focused industries.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 

Offering a complete range of patent services and well versed in all scientific and engineering disciplines, Finnegan is the best-rounded boutique in the country. The embodiment of this versatility, Boston’s Linda Thayer combines the best traits of a litigator, prosecutor, portfolio manager and strategist and has a broad technical compass in the computer and electronics fields. Well-suited to post-grant proceedings with her blended skills, she has been contributing significantly to the firm’s leading PTAB practice. Leslie McDonell flies Finnegan’s flag in the local life sciences scene. She takes the lead advising Vertex Pharmaceuticals on prosecution and global IP strategy and provides broad support to Biogen.

Fish & Richardson

Boston is where it all began for Fish, a firm many now consider to be the United States’ leading patent specialist. Writing many of the firm’s headlines, the patent litigation team continues to garner incredible success in all forums – including the district courts, the Federal Circuit, the International Trade Commission (ITC) and the PTAB – and to service the highest level of demand for representation. Undoubtedly one of the busiest and best trial lawyers in the country is Frank Scherkenbach whose recent achievements include, but are not limited to, reversing a $2.5 billion jury verdict against client Gilead Sciences; winning a major ITC battle for Aspen Aerogels against two Chinese competitors; and emerging victorious from a jury trial representing Microsoft against patent assertion entity Parallel Networks. Focusing on medical device, software, networking and electronics cases, Adam Kessel is another adept litigator in the Boston office. Filing many thousands of US and foreign patents annually, Fish is also prolific in prosecution; not just a filing mill, though, its bench is deep with top strategists, including medical technology experts Peter Fasse and Michael Hamlin. “Peter is a key business partner whose work cultivating and advancing product portfolios results in tremendous growth. A consummate professional, Peter provides pragmatic advice tailored to the needs of his clients.” “Mike is focused on doing what’s right for his clients and finds and executes practical solutions that don’t cost a lot when they don’t need to. His ability to assess the strength of portfolios, evaluate new technologies and close deals is excellent.” Fish has a “vibrant pharmaceutical and biotechnology prosecution practice”, taking the lead on which are Janis Fraser and Anita Meiklejohn. Fraser, who earned her biochemistry PhD from the Massachusetts Institute of Technology, is a thought leader on personalised medicine and other life sciences topics. “Everything you want in a partner”, Meiklejohn is hailed as a “thoughtful, collaborative and technically gifted prosecutor”.

Foley & Lardner LLP

Venerable firm Foley & Lardner is steeped in intellectual property to a degree that many of its full-service competitors are not. This is manifested in the breadth of Foley’s patent offering which embraces, in a highly integrated way, all aspects of prosecution, counselling, litigation, post-grant proceedings and transactions. The holistic quality of the firm’s advice is enhanced further by the multidisciplinary expertise showcased by many of its top lawyers: Boston’s Matthew Lowrie, for example, is not just a top national trial lawyer but also a sage counsellor and transactions broker; in a similar vein, electronics co-chair Christopher McKenna prosecutes and litigates with aplomb; renaissance man John Lanza strategically and commercially guides clients on rights acquisition, transfer and enforcement as a member of the manufacturing and technology industry teams and the electronics and private equity and venture capital practices.

Foley Hoag LLP

Foley Hoag has cultivated a deep knowledge of the life sciences industry and fields a well-rounded and technically accomplished team on behalf of a colourful catalogue of established and emerging pharmaceutical, biotechnology, medical device and healthcare companies. For those looking to procure, protect and commercialise valuable patents, Dana Gordon is the talk of the town. He is a brilliant scientist – he earned his PhD in organic chemistry from Yale, completed a post-doctoral fellowship at Harvard and oversaw an independent research programme at Brandeis – but also understands the finer points of patent strategy. Donald Ware and Barbara Fiacco, meanwhile, are the go-to lawyers when litigation looms. Distinguished by his combination of trial experience and Food and Drug Administration regulatory knowledge, Ware makes a great captain of the litigation practice; Fiacco mounts the sturdiest defences for drug companies in high-stakes disputes. Deploying a richly strategic playbook for telecoms, IT and software clients, Philip Swain is the ensemble’s most experienced high-tech battler.

Goodwin Procter LLP

Goodwin Procter is Boston’s unequivocal best patent and technology transactions firm and a guiding light for pharmaceutical, biotechnology, medical device and high-tech companies alike. Luminaries of the life sciences include Kingsley Taft, Duncan Greenhalgh and Sarah Solomon, each of whom has had an ample volume of meaty deals to tuck into lately. Industry practice co-chair Taft has acted for Moderna Therapeutics on several matters, including a $500 million equity financing round – one of 2018’s largest biotechnology private financings – and represented exciting drug discovery company Warp Drive Bio on a collaboration with Roche. “A business-savvy and creative lawyer with amazing attention to detail”, Greenhalgh has been advising Malaysian sovereign wealth fund Xeraya Capital on various life sciences investment opportunities and local venture-backed pharma company Lysosomal Therapeutics on prosecution strategy and transactions. “A terrific, tough, straightforward and direct negotiator who doesn’t labour unimportant points”, Solomon oversaw a global strategic collaboration between her client Wave Life Sciences and Takeda to develop and commercialise therapies for central nervous system disorders, in addition to working with Taft for Moderna. All three are at the cutting edge of developments in the industry. Moving to the high-tech side, fintech experts Joel Lehrer and Stephen Charkoudian are deal makers, not deal killers. Lehrer is at the forefront of areas such as machine learning and is advising DataRobot on prosecution and transactions. Coordinating effectively with colleagues in other groups – something all the firm’s IP lawyers do regularly and astutely – Charkoudian has been acting for wireless security alarm company SimpliSafe on an M&A deal. Both lawyers contribute to Goodwin’s Founders Workbench, an excellent learning resource and toolkit for entrepreneurs. Patent litigation is another cornerstone practice for the IP lawyers in Boston and, linking up as necessary, Douglas Kline, Daryl Wiesen and Anthony Downs form a special operations team for prestigious clients. IP litigation chair Kline often takes over matters from other firms because of his skill in turning around difficult cases; his extensive Federal Circuit experience also inspires confidence of lasting wins. Gold-rated lawyer Wiesen masterminds many victories for pharmaceutical clients litigating under the Hatch-Waxman Act. Veteran trial maestro Downs cannot be confined to any one technical area – his superlative advocacy skills can make any technology relatable and any story convincing.

Greenberg Traurig LLP

With its 100 USPTO-registered attorneys, Greenberg Traurig gets its hands on all types of intriguing and cutting-edge innovations – and it protects and defends them with zeal. Some of the prosecution and portfolio management group’s heaviest hitters can be found in Boston, making the firm’s office there strategically significant in the context of its sweeping national patent practice. For example, there is global life sciences and medical technology group co-chair David Dykeman, a world-class strategist named to the IAM Patent 1000 and the IAM Strategy 300 this year. “David is a pre-eminent IP attorney for venture-backed companies” such as IlluminOss Medical, whose worldwide portfolio he has developed; he also serves as trusted adviser to several eminent academic institutions. Dykeman’s local lieutenant, experienced engineer Roman Fayerberg, is also highly rated; “If you’re doing something important, Roman is a great patent attorney to have by your side. He understands the most complex inventions and prior art and helps you to get the most out of your filings. Further, his diligence and timeliness are outstanding.” Boston is also home to pharmaceutical, biotechnology and chemical maven Melissa Hunter-Ensor, who serves as vice chair of the global prosecution group, and Chinh Pham, the co-leader of the emerging technologies practice. Pham is a notable nanotechnology expert and works with Nanocomp Technologies, which is doing exciting things in the aerospace industry.

Holland & Knight LLP

The first choice of an illustrious cadre of innovators, Holland & Knight does error-free prosecution and acquits itself with distinction in impact patent litigation. Its IP lawyers are very active in terms of thought leadership, too, and are out in the market speaking and writing on hot patent topics and emerging issues, such as blockchain technology. The top dog in Boston is Joshua Krumholz, a “battle-tested trial lawyer” who knows how to fight but who always looks for a business resolution. Work for Avaya, Hasbro, T-Mobile and Verizon has kept him busy of late. The main man for prosecution, transactions and opinions is electrical engineering and high-tech aficionado Brian Colandreo.

Lando & Anastasi LLP

Lando & Anastasi builds trust with each client by providing a personal and tailored service directed towards the realisation of commercial value from their intellectual property. Unsurprisingly, then, it gets excellent feedback from the marketplace. A referee enthuses: “Lando & Anastasi has procured quality enforceable patents for us that are strongly related yet distinct and which collectively cover everything we need them to cover without prematurely publicising the things we want to keep private; it has also created an excellent roadmap for us going forward.” An empathetic lawyer with unerring strategic instincts and great judgement, Peter Lando takes the lead on patent and technology transactions. “He listens to his clients carefully and then engages in deep discussions with inventors that enable him to fully understand the essence of an invention; the thoroughness of the claims he then articulates means that his patents prevail in infringement litigation. Beyond practice, Peter is generous with his personal time and expertise and does much to educate law students on patent matters.” His focused industries include chemical, cleantech and medical devices. In Craig Smith, Lando & Anastasi also has a seasoned litigator with a track record facilitating early wins. He is cool as a cucumber in court – he never gets rattled or tips his hand too early.

McCarter & English LLP 

With its many PhDs and experienced USPTO navigators, McCarter & English is a prosecution powerhouse and builds impregnable protection matrices for a slew of leading life sciences companies. As attested to by the IAM Patent 1000’s recommendation of three trial lawyers in Boston, the firm also makes light work of patent litigation. John Gutkoski stands out for his many successes representing pharmaceutical innovators in Hatch-Waxman Act litigations, though his trial skills see him through whatever technology is at issue. Lee Carl Bromberg and Erik Paul Belt tackle a broader range of IP cases but are nonetheless proficient in patents for it. Bromberg is an expert in licensing disputes; Belt, a former president of the Boston Patent Law Association, puts in resonant performances for plaintiffs and defendants.

McDermott Will & Emery

Unique selling points for McDermott include the comprehensiveness of its patent practice, rich life sciences industry experience and unbreakable courtroom confidence, all of which are showcased by its crew in Boston. McDermott has individuals recommended on each of the IAM Patent 1000 prosecution, litigation and transactions tables, including high-tech whizz Edward Gordon, who is listed on two (prosecution and transactions). Gordon’s clients include Google, whose network infrastructure patents he manages. Immunology PhD Robert Underwood helps his clients to make rapid advances thanks to the strategic perspicacity of his counsel; under the firm’s Life Sciences Entrepreneurs Acceleration programme he has acted for Applied Therapeutics from its incorporation in 2016 to initiating human clinical trials in 2018. Kristin Connarn, together with Underwood, has gotten great results for Massachusetts-based public biotechnology company Kiniksa Pharmaceuticals since making the connection in 2016; it now has four drugs in the pipeline and recently completed a $125 million initial public offering. The newest member of the squad, Princeton molecular biology PhD Kristina Bieker-Brady joined from Clark+Elbing in March 2018; as an IP value creator she is “thorough and incredibly creative”. McDermott has an American College of Trial Lawyers fellow in Sarah Chapin Columbia. She has been handling a multi-layered dispute for Amgen against Sanofi and earned a major trial victory which the Federal Circuit affirmed on all but one ground (validity under Section 112); the case is now back in the district court.

McNeill Baur PLLC

“McNeill Bauer has been doing an impressive job in the life sciences sector and assembled a fantastic team of innovative attorneys who do great work.” The chief architect of this success is Rebecca McNeill, a top biotechnologist with in-house experience and training from leading boutique Finnegan. She affords her clients a hands-on, high-quality, flexible and cost-effective prosecution, counselling and transactions service.

Mintz

Intellectual property is a central pillar of the broader commercial, litigation and transactional practice at Mintz. With popular Peter Corless in the fold, the set’s life sciences skills are especially well honed: Corless is a “hugely talented and incredibly knowledgeable chemist and a solid, hard-working, nose-to-the-grindstone sort of attorney who gets things done”. Domestic and international prosecution and portfolio management is his metier. David Conlin also knows the ins and outs of the pharmaceutical and biotechnology industries, having overseen the procurement of thousands of patents and litigated extensively under the Hatch-Waxman Act. For a world-class strategist in the high-tech theatre, look to Michael Renaud. A licensing connoisseur with extensive ITC litigation experience, he is listed on the IAM Patent 1000 transactions table for 2019 and retains his spot on the litigation list.

Morgan Lewis & Bockius LLP

In recognition of its life sciences mastery, Morgan Lewis secures its first inclusion in the IAM Patent 1000 Massachusetts rankings this year; its multi-disciplinary approach to the industry puts clients on a sure footing come what may. A top local lawyer in Boston is Stephen Altieri, a repository of trust for emerging biotechnology companies. For many of his clients, he is their only patent counsel and, as such, plays a critical role in their strategic and commercial development. Engaging extensively in deal work lately, he has been acting for Finch Therapeutics, which innovates in the microbiomes area, successfully handling its Series A and B financings; in the immuno-oncology space, he has been working for Shattuck Labs on a research collaboration with Takeda. “Steve conducts thorough research and presents IP strategies that can be easily understood and implemented by his clients’ technical and management teams. He brings things in below budget while meeting very aggressive deadlines.” On the computer technology side, the local office maintains a close relationship with Harvard University through Steven Frank; an experienced transactional lawyer, he knows the ingredients that make a commercially attractive patent.

Nixon Peabody LLP

Nixon Peabody has lots of exciting things going on in the life sciences and healthcare sectors; out in California, Seth Levy is impressing at every turn in his work supporting universities with technology transfer; in Boston, meanwhile, Ronald Eisenstein and David Resnick are operating at the vanguard of developments in gene therapy and microbiomes. A basic description of Eisenstein’s role would say he is a portfolio manager, but his practice is highly nuanced; creating IP value and ringfencing competitive market positions for clients as a strategist is what he is all about. Also notable is the strength and extent of Eisenstein’s international connections. Resnick understands what makes his clients tick in a deeply intuitive way and, showcasing impressive range, partners closely with dynamic start-ups, leading research institutions and large international corporations.

Proskauer Rose LLP

Substantial growth in the life sciences domain is an important thread of Proskauer Rose’s recent narrative. The firm’s talent acquisition efforts of the past few years have really paid off and created an enviable level of pull among top pharmaceutical companies, such as Shire, Takeda and Gilead entity Kite Pharma. Exceptional scientist Fangli Chen plays a starring role for these clients, marshalling a brilliant and large team of associates to ensure perfect delivery on portfolio management tasks and more contentious matters such as inter partes reviews. She steps into the shoes of her clients and works hard to get to the bottom of complex problems before coming out the other side with satisfying business resolutions. Should a dispute develop into a full-on battle, co-head of the IP and patent law practices Steven Bauer is there to take charge and sort it all out. He has a well justified reputation for being assertive – he comes out hard filing for preliminary injunctions, for example – but also for being fair, which he is hugely respected for. He is currently acting for Amgen in a closely watched fight against Genentech under the Biologics Price Competition and Innovation Act arising out of Amgen’s development and commercialisation of a biosimilar to monoclonal antibody cancer therapy Avastin – a good illustration of the cutting-edge nature of Bauer’s, and the firm’s, work. Proskauer Rose also maintains a dynamic transactional practice representing companies and private equity and other investors. Taking the reins of this practice, Boston’s Joseph Capraro is a beacon for many emerging technology entities and start-ups. He also plays another important role – that of post-grant practice leader.

Ropes & Gray LLP

Ask about Ropes & Gray’s international patent and technology transactions practice and you will hear uniformly good things; the firm has top-quality deal makers stationed in Boston, Chicago, London, New York, San Francisco, Silicon Valley and Shanghai who frequently and seamlessly coordinate on acquisitions, collaborations and other agreements that shape industries. Its presence in China has come to be of strategic significance lately; the life sciences deal market there is booming and Ropes is capturing a lot of it. Closer to home, David McIntosh has been making the most of the strong economy and vibrant Boston scene. He is working with Massachusetts-based Homology Medicines, which has created a highly efficient single component gene editing technology system on an R&D collaboration with Novartis. Head of the IP transactions group McIntosh is a life sciences industry insider who knows what is marketable and when his opponents’ demands are unreasonable. His counterpart on the technology, media and telecoms side is Edward Black, a “super-commercial lawyer who knows IP law in its entirety”. Peers like his style, commenting: “He is firm on his positions but is not doctrinarian or confrontational for the sake of it.”

Wilmer Cutler Pickering Hale and Dorr LLP

WilmerHale commands immense respect nationally as an unstoppable IP litigation force but also as a great all-round patent firm; the group in Boston reflects this locally, dominating the IAM Patent 1000 litigation table for Massachusetts and having individuals on the prosecution and transactions tables, too. You cannot mention WilmerHale without bringing William Lee into the conversation; he epitomises the firm’s courtroom courage and ability to take on the most challenging matters and win. “Bill is the best of the best in patent litigation. His trial presence is incredible, although he isn’t one of the flamboyant or theatrical types; calm, unbelievably smart and persuasive, he gets it done without showing off.” It is not just Bill though – the firm’s trial bench is a constellation of stars: unfailingly impressive, Lisa Pirozzolo is doing all the right things as co-chair of the IP litigation group. “Lisa is both aggressive and completely reasonable to deal with; she’s a smart, thoughtful and practical litigator.” Coming to the fore as an expert on trade secret matters is Mark Matuschak, one of the most senior trial lawyers in Boston – or New York for that matter, where he also maintains a desk. Often working together, Cynthia Vreeland and technical marvel Peter Dichiara give their high-tech clients a strong one-two punch. Colleen Superko and Jeffrey Johnson anchor the prosecution and transactions practices respectively. A whisperer to pharmaceutical innovators, Superko has a profound understanding of the role of intellectual property in the life sciences industry. Johnson is prolific as a deal broker and has drafted and negotiated just about every type of deal possible.

Wolf, Greenfield & Sacks, PC

Venerable Boston outfit Wolf Greenfield, the largest IP boutique in the city, is stacked with technical talent – nearly all of its practitioners have science or engineering degrees – and is a market leader in both high-efficiency and high-quality patent prosecution. Representatives from all branches of the practice can be found in the IAM Patent 1000 this year. Starting with software and network communications, Edward Russavage is the top choice; “incredibly smart technically”, he practises at the vanguard of developments in areas such as artificial intelligence and the Internet of Things. Neil Ferraro is a wizard in the mechanical arts with strong industry knowledge built on a foundation of experience working as an IP attorney at the Ford Motor Company. Patrick Waller and Jenny Chen are leading biotechnologists with PhDs in genetics and pharmacology respectively. Responsible for the smooth running of the firm as president and managing partner, Timothy Oyer also undertakes important strategic projects in the chemical and materials technology areas and, alongside Waller, has been advising Oxford Nanopore as it enters the US market. Wolf Greenfield performs adroitly in all patent practice areas, not just prosecution. Underscoring this, Jason Honeyman earns recognition on all three individual tables and garners excellent feedback as an IP polymath; “Jason is absolutely wonderful – he has a great sense of his clients’ objectives and how to fulfil them; he’s bang up to date on all relevant legal developments and is a confident lawyer who never gets rattled.” Edward Gates is ideally placed to give clients vital strategic overviews, having practised in licensing, portfolio development, counselling and litigation for nearly four decades. He is chiefly known for his transactional prowess and is one part of an elite IP commercialisation practice; distinguished scientist and co-inventor of two US patents, Jeffrey Hsi is another. The firm’s litigation and prosecution expertise dovetails neatly in the post-grant area, leading figures in which are Richard Giunta and Randy Pritzker; they recently linked up to file three inter partes reviews for RPX and invalidated a patent asserted by an NPE. Trial and appellate work is the metier of Michael Albert, a 15-year leader of the litigation group who extinguishes infringement fires in all areas of technology.

Other recommended experts

Trial lawyer Steven Cherny is an elevated strategic thinker with a rapier-like mind. He operates out of Quinn Emanuel’s Boston office. Jerry Cohen of Burns & Levinson continues to enjoy a distinguished career in intellectual property, handling an exceptionally broad range of patent, trademark, copyright and trade secret matters, including rights procurement, licensing and litigation. With more than 40 years in the game, there is little he has not seen. Flying the flag of Banner Witcoff in Boston, John P Iwanicki sets out to achieve the commercial goals of the life sciences and biotechnology companies he represents, and he never misses the mark. His blended litigation and prosecution skills give him a 360-degree perspective on patent matters. Warren Nachlis takes full advantage of Jones Day’s global platform to assist technology companies of all stripes to forge worldwide connections. Instrumental in Dechert’s rise to prominence in the life sciences is Andrea Reid, the co-leader of its global industry practice. Having spent three decades advising pharmaceutical companies, she knows what makes them tick on a strategic level and her ability to harness the group’s litigation and counselling experts ensures her clients get holistic counsel. She takes care of prosecution matters and deals on behalf of Merck. Bruce D Sunstein at Sunstein Kann Murphy & Timbers secures ironclad protection for his clients; his patents have been tested to the limit in litigation – but never broken. His granular knowledge of patent law has seen him called as an expert witness in many litigations. White & Case is the ideal platform for a global company like Bayer, and Anita Varma is the ideal lawyer, too. Working hands on, she helps her clients to grow as international businesses and tailors her approach neatly to that end. The USPTO-registered lawyer is also qualified to practise before the EPO and regularly spends time in the firm’s London office. James Velema chairs the biotechnology patent prosecution practice at Lathrop Gage. As the named inventor on several US patents, he understands the passion his clients put into their innovations; feeding off it, he devotes maximum effort to ensuring that they get abiding protection.

Individuals: litigation

  • Steven M Bauer - Proskauer Rose LLP
  • Steven C Cherny - Quinn Emanuel Urquhart & Sullivan LLP
  • Sarah Chapin Columbia - McDermott Will & Emery
  • Robert S Frank Jr - Choate Hall & Stewart LLP
  • William F Lee - Wilmer Cutler Pickering Hale and Dorr LLP
  • Eric J Marandett - Choate Hall & Stewart LLP
  • Frank Scherkenbach - Fish & Richardson
  • Daryl L Wiesen - Goodwin Procter LLP
  • Erik Paul Belt - McCarter & English LLP 
  • Lee Carl Bromberg - McCarter & English LLP 
  • Michael H Bunis - Choate Hall & Stewart LLP
  • Jerry Cohen - Burns & Levinson LLP
  • David G Conlin - Mintz
  • J Anthony Downs - Goodwin Procter LLP
  • Barbara Fiacco - Foley Hoag LLP
  • John T Gutkoski - McCarter & English LLP
  • Douglas J Kline - Goodwin Procter LLP
  • Joshua C Krumholz - Holland & Knight LLP
  • Matthew B Lowrie - Foley & Lardner LLP
  • Mark G Matuschak - Wilmer Cutler Pickering Hale and Dorr LLP
  • Carlos Perez-Albuerne - Choate Hall & Stewart LLP
  • Lisa J Pirozzolo - Wilmer Cutler Pickering Hale and Dorr LLP
  • Linda J Thayer - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Donald R Ware - Foley Hoag LLP
  • Michael A Albert - Wolf, Greenfield & Sacks, PC
  • Peter M Dichiara - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jason Honeyman - Wolf, Greenfield & Sacks, PC
  • Adam Kessel - Fish & Richardson
  • Paul D Popeo - Choate Hall & Stewart LLP
  • Craig Smith - Lando & Anastasi LLP
  • Philip C Swain - Foley Hoag LLP
  • Cynthia D Vreeland - Wilmer Cutler Pickering Hale and Dorr LLP

Individuals: prosecution

  • Ronald I Eisenstein - Nixon Peabody LLP
  • Edward R Gates - Wolf, Greenfield & Sacks, PC
  • Brenda Herschbach Jarrell - Choate Hall & Stewart LLP
  • Stephen Altieri - Morgan Lewis & Bockius LLP
  • Joseph A Capraro Jr - Proskauer Rose LLP
  • Fangli Chen - Proskauer Rose LLP
  • Y Jenny Chen - Wolf, Greenfield & Sacks, PC
  • Brian J Colandreo - Holland & Knight LLP
  • Kristin Connarn - McDermott Will & Emery
  • Peter F Corless - Mintz
  • David J Dykeman - Greenberg Traurig LLP
  • Karen L Elbing - Clark+Elbing LLP 
  • Dean Farmer - Cooley LLP
  • J Peter Fasse - Fish & Richardson
  • Roman Fayerberg - Greenberg Traurig LLP
  • Neil P Ferraro - Wolf, Greenfield & Sacks, PC
  • Janis Fraser - Fish & Richardson
  • Richard F Giunta - Wolf, Greenfield & Sacks, PC
  • Dana M Gordon - Foley Hoag LLP
  • Edward A Gordon - McDermott Will & Emery
  • Michael R Hamlin - Fish & Richardson
  • Jason Honeyman - Wolf, Greenfield & Sacks, PC
  • Melissa Hunter-Ensor - Greenberg Traurig LLP
  • John P Iwanicki - Banner Witcoff 
  • Peter C Lando - Lando & Anastasi LLP
  • John D Lanza - Foley & Lardner LLP
  • Charles E Lyon - Choate Hall & Stewart LLP
  • Leslie A McDonell - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Christopher McKenna - Foley & Lardner LLP
  • Rebecca McNeill - McNeill Baur PLLC
  • Anita L Meiklejohn - Fish & Richardson
  • Timothy J Oyer - Wolf, Greenfield & Sacks, PC
  • Chinh H Pham - Greenberg Traurig LLP
  • Randy Pritzker - Wolf, Greenfield & Sacks, PC
  • Andrea LC Reid - Dechert LLP
  • David Resnick - Nixon Peabody LLP
  • Edward J Russavage - Wolf, Greenfield & Sacks, PC
  • Bruce D Sunstein - Sunstein Kann Murphy & Timbers LLP 
  • Colleen Superko - Wilmer Cutler Pickering Hale and Dorr LLP
  • Linda J Thayer - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Robert H Underwood - McDermott Will & Emery
  • Anita Varma - White & Case LLP
  • James Velema - Lathrop Gage LLP
  • Patrick RH Waller - Wolf, Greenfield & Sacks, PC

Individuals: transactions

  • Edward G Black - Ropes & Gray LLP
  • Edward R Gates - Wolf, Greenfield & Sacks, PC
  • Kingsley Taft - Goodwin Procter LLP
  • Stephen Altieri - Morgan Lewis & Bockius LLP
  • Kristina Bieker-Brady - McDermott Will & Emery
  • Joseph A Capraro Jr - Proskauer Rose LLP
  • Stephen G Charkoudian - Goodwin Procter LLP
  • David J Dykeman - Greenberg Traurig LLP
  • Steven Frank - Morgan Lewis & Bockius LLP
  • Edward A Gordon - McDermott Will & Emery
  • Duncan A Greenhalgh - Goodwin Procter LLP
  • Jason Honeyman - Wolf, Greenfield & Sacks, PC
  • Jeffrey D Hsi - Wolf, Greenfield & Sacks, PC
  • Jeffrey P Johnson - Wilmer Cutler Pickering Hale and Dorr LLP
  • Peter C Lando - Lando & Anastasi LLP
  • Joel E Lehrer - Goodwin Procter LLP
  • Charles E Lyon - Choate Hall & Stewart LLP
  • David M McIntosh - Ropes & Gray LLP
  • Warren L Nachlis - Jones Day
  • Michael T Renaud - Mintz
  • Edward J Russavage - Wolf, Greenfield & Sacks, PC
  • Sarah A Solomon - Goodwin Procter LLP
  • Anita Varma - White & Case LLP
  • Scott Weston - Cooley LLP